Contents - doe-std-1187-20050003

DOE-STD-1187-2005

CONTENTS

FOREWORD ................................................................................................ii

1. SCOPE ...................................................................................................................................... 5

2. BACKGROUND ...................................................................................................................... 5

2.1. Data Sources.................................................................................................................................................5

2.2. Site Registry Coordinator .............................................................................................................................6

2.3. Data Submission ...........................................................................................................................................6

2.4. Worker Confidentiality Protection................................................................................................................6

2.5. Dissemination of Information.......................................................................................................................8

3. ROSTER OF BERYLLIUM-ASSOCIATED WORKERS ...................................................... 8

4. BERYLLIUM-RELATED MEDICAL SURVEILLANCE ................................................... 11

4.1. Beryllium Lymphocyte Proliferation Test (LPT) Results...........................................................................11

4.2. Smoking Data .............................................................................................................................................12

4.3. Chest X-Ray Results...................................................................................................................................13

4.4. Spirometry Results .....................................................................................................................................14

4.5. DLCO Results ............................................................................................................................................16

4.6. Referral/Follow-Up ....................................................................................................................................17

4.7. Bronchoaveolar Lavage (BAL) LPT Results..............................................................................................18

4.8. Transbronchial Biopsy and BAL Pathology Results ..................................................................................19

4.9. High-resolution Computed Tomography (CT) Results...............................................................................20

4.10. Cardiopulmonary Exercise Testing (CPET) Results...................................................................................21

4.11. CBD Evaluation Results.............................................................................................................................22

4.12. Beryllium-Induced Dermatitis ....................................................................................................................23

iii